For research use only. Not for use in humans.

Blosozumab (Anti-SOST / Sclerostin)

Synonyms: LY2541546 Cat.No.A2787 Purity:99%

Blosozumab (anti-SOST/ Sclerostin) is a humanized monoclonal antibody against sclerostin. Blosozumab stimulates bone formation, reduces bone resorption, and has the potential to be used in the research of osteoporosis. MW: 144.88 kD.

Blosozumab (Anti-SOST / Sclerostin)

Quality Control

Batch: A278701 Purity: 99% Protein concentration: 6.25mg/ml Endotoxin Level: ＜1EU/mg

99

Mechanism of Action

Description	Blosozumab (anti-SOST/ Sclerostin) is a humanized monoclonal antibody against sclerostin. Blosozumab stimulates bone formation, reduces bone resorption, and has the potential to be used in the research of osteoporosis. MW: 144.88 kD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/22106037/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1132758-87-2
Molecular Weight	144.88
Isotype	Human IgG4SP
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.